Farmalider was founded in 1986 and, since its inception, has established itself as one of the leading innovators in health projects in Spain through the constant improvement of pharmaceutical products. The company has now decided to invest in biotechnology to expand its reach, and one of its new flagship projects, AGAcell, is being driven by Ideeea Therapeutics, a company it leads with the support of Hospital Clínico San Carlos.
Gaceta de Salud has interviewed Marisa Berenguer, CEO of Farmalider and Ideeea Therapeutics, who was recently awarded the Entrepreneur of the Year Prize at the Spanish Association of Women Entrepreneurs Awards for her work on AGAcell—an unprecedented preclinical treatment for androgenetic alopecia that has shown promising results.
